Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abdominal Aortic Aneurysm
Medtronic Launches New Medical Device In U.S. To Improve Treatment of Aortic Aneurysms
December 12th, 2008
Adding to its recent endovascular aortic repair (EVAR) innovations, Medtronic, Inc. (NYSE: MDT), announced the U.S. launch of the Talent Abdominal Stent Graft on the Xcelerant Hydro Delivery System. EVAR is a treatment for aortic aneurysm, a dangerous bulge or weakening in the body's main artery that can rupture with fatal consequences if left untreated. In the United States, abdominal aortic aneurysms – the most common type – are responsible for approximately 15,000 deaths annually. Worldwide, it is estimated that more than one million people are living with undiagnosed aortic aneurysms, and that 95 percent of these could be successfully treated if detected before...
Source: Health Business Week (2008-12-12)
|
